Table 2.
Association of CD97 expression with patient mutational status in the TCGA data set
| Total | CD97 low (Z <1) | CD97 high (Z ≥1) |
p Value |
||
|---|---|---|---|---|---|
| T test | Fischer exact test | ||||
| FLT3, No. (%) | 0.1005 | ||||
| Present | 49 (28.3) | 38 (77.5) | 11 (22.4) | 0.0008 | |
| Absent | 124 (71.67) | 109(87.9) | 15 (12.1) | ||
| IDH1, No. (%) | 0.09 | 0.4718 | |||
| Mutated | 16 (9.2) | 15 (93.7) | 1 (6.2) | ||
| Wild type | 157 (92.3) | 132 (84.0) | 25 (15.9) | ||
| IDH2, No. (%) | 0.77 | 0.7238 | |||
| Mutated | 17 (9.8) | 14 (82.3) | 3 (17.6) | ||
| Wild type | 156 (90.1) | 133 (85.2) | 23 (14.7) | ||
| RUNX1, No. (%) | 0.0002 | 0.070 | |||
| Mutated | 17 (9.8) | 17 (100) | 0 (0) | ||
| Wild type | 156 (90.1) | 130 (83.3) | 26 (16.6) | ||
| TET2, No. (%) | 0.10 | 0.1311 | |||
| Mutated | 15 (8.6) | 15 (100) | 0 (0) | ||
| Wild type | 158 (91.3) | 132 (83.5) | 26 (16.4) | ||
| NRAS, No. (%) | 0.57 | 1 | |||
| Mutated | 12 (6.9) | 10 (83.3) | 2 (16.6) | ||
| Wild type | 161 (93.0) | 137 (85.0) | 24 (14.9) | ||
| CEBPA, No. (%) | 0.54 | 0.6944 | |||
| Mutated | 13 (7.5) | 12 (92.3) | 1 (7.6) | ||
| Wild type | 160 (92.5) | 135 (84.3) | 25 (15.6) | ||
| WT1, No. (%) | 0.42 | 0.3624 | |||
| Mutated | 10 (5.7) | 10 (100) | 0 (0) | ||
| Wild type | 163 (94.2) | 137 (84.0) | 26 (15.9) | ||
| DNMT3A, No. (%) | 0.122 | 0.1453 | |||
| Mutated | 45 (26.0) | 35 (77.7) | 10 (22.2) | ||
| Wild type | 128 (73.9) | 112 (87.5) | 16 (12.5) | ||
| NPM1, No. (%) | <0.0001 | 0.0033 | |||
| Mutated | 48 (27.7) | 34 (70.8) | 14 (29.1) | ||
| Wild type | 125 (72.3) | 113 (90.4) | 12 (9.6) | ||
| TP53 | 0.34 | ||||
| Mutated | 14 (8.09) | 13 (92.8) | 1 (7.1) | 0.6970 | |
| Wild type | 159 (91.9) | 134 (84.2) | 25 (15.7) | ||